Emerging and unusual gram-negative infections in cystic fibrosis

Area of Science:

• Microbiology
• Infectious Diseases
• Pulmonology

Background:

• Cystic fibrosis (CF) patients experience chronic airway infections, leading to frequent antibiotic use.
• This selective pressure drives the emergence of antibiotic-resistant organisms.
• Beyond Pseudomonas aeruginosa, inherently resistant gram-negative species are increasingly prevalent in CF airways.

Purpose of the Study:

• To highlight the growing challenge of multidrug-resistant gram-negative infections in cystic fibrosis.
• To identify emerging pathogens and the difficulties in their laboratory identification.
• To underscore the clinical significance and management challenges posed by these resistant organisms.

Main Methods:

• Literature review and synthesis of current research on microbial resistance in CF.
• Analysis of epidemiological trends in CF pathogen identification.
• Discussion of phenotypic and genotypic identification challenges for related gram-negative species.

Main Results:

• Common CF pathogens like Pseudomonas aeruginosa exhibit increasing multidrug resistance.
• Emerging resistant gram-negative species include Burkholderia cepacia complex, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, Ralstonia species, and Pandoraea.
• These species are often phenotypically similar, complicating accurate laboratory identification.

Conclusions:

• The increasing prevalence of diverse, inherently resistant gram-negative bacteria poses a significant threat to CF patient care.
• Accurate and timely laboratory identification is critical for effective treatment and infection control.
• Certain species, like the Burkholderia cepacia complex, are associated with poor prognosis, necessitating specialized management strategies.